---
$id: https://graph.org.ai/products/commodity/51131827
$type: Product
source: UNSPSC
code: "51131827"
title: "Eltrombopag olamine"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eltrombopag olamine

**UNSPSC Code**: 51131827
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an agent affecting blood and body fluid C25H22N4O4.2C2H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U07F515LG, chemically known as (1,1'-biphenyl)-3-carboxylic acid, 3'-((2z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-, compound with 2-aminoethanol (1:2), but more generally known as eltrombopag olamine, which bears US NIH Compound Identifier 9915926. European Medicines Agency schedules Eltrombopag olamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30141. Most nations, for tariff and trade purposes, schedule eltrombopag olamine under HS 29331900 and SITC 51571. As of Q4 2014, ELTROMBOPAG OLAMINE remains US FDA's Preferred Term for this commodity. Eltrombopag olamine bears US NLM identifiers UMLS ID C1880492 and NCI Concept Code C62501. SMILES: CC1CCC(CC1C)N2C(=O)/C(=N\NC3CCCC(C3O)C4CCCC(C4)C(=O)O)/C(=N2)C.C(CO)N.C(CO)N.

